Correlation Between Aridis Pharmaceuticals and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Aridis Pharmaceuticals and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aridis Pharmaceuticals and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aridis Pharmaceuticals and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Aridis Pharmaceuticals and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aridis Pharmaceuticals with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aridis Pharmaceuticals and Cadrenal Therapeutics,.
Diversification Opportunities for Aridis Pharmaceuticals and Cadrenal Therapeutics,
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Aridis and Cadrenal is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Aridis Pharmaceuticals and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Aridis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aridis Pharmaceuticals are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Aridis Pharmaceuticals i.e., Aridis Pharmaceuticals and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between Aridis Pharmaceuticals and Cadrenal Therapeutics,
If you would invest 27.00 in Aridis Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Aridis Pharmaceuticals or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.55% |
| Values | Daily Returns |
Aridis Pharmaceuticals vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| Aridis Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Cadrenal Therapeutics, |
Aridis Pharmaceuticals and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aridis Pharmaceuticals and Cadrenal Therapeutics,
The main advantage of trading using opposite Aridis Pharmaceuticals and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aridis Pharmaceuticals position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.| Aridis Pharmaceuticals vs. Akari Therapeutics PLC | Aridis Pharmaceuticals vs. Aditxt Inc | Aridis Pharmaceuticals vs. ABVC Biopharma | Aridis Pharmaceuticals vs. Reviva Pharmaceuticals Holdings |
| Cadrenal Therapeutics, vs. Cue Biopharma | Cadrenal Therapeutics, vs. Tff Pharmaceuticals | Cadrenal Therapeutics, vs. Eliem Therapeutics | Cadrenal Therapeutics, vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |